No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

Epidural glucocorticoid injection is an intervention commonly used for managing lumbosacral radicular pain. The goal of the injection is to administer glucocorticoids to the epidural space to ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

For patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the ...

Vitamin C may be one of the top potential supplements to reduce cortisol and is readily abundant in several formats. However, ...

Discover a trial that included 135 adults, randomly assigned to receive either inebilizumab or a placebo for a 52-week ...

Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

In mice, stress altered the way that the brain packaged memories, resulting in an unnecessary fear response — but drugs were ...

Variants of the PER3 gene disrupt adrenal adaptation to winter light, leading to serotonin disruption and depression-like ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...